CHB vs. SPY
Compare and contrast key facts about Global X China Biotech Innovation ETF (CHB) and SPDR S&P 500 ETF (SPY).
CHB and SPY are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CHB is a passively managed fund by Global X that tracks the performance of the Solactive China Biotech Innovation Index. It was launched on Sep 22, 2020. SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993. Both CHB and SPY are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CHB or SPY.
Correlation
The correlation between CHB and SPY is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CHB vs. SPY - Performance Comparison
Key characteristics
Returns By Period
CHB
N/A
N/A
N/A
N/A
N/A
N/A
SPY
4.34%
2.33%
10.15%
23.99%
14.44%
13.21%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
CHB vs. SPY - Expense Ratio Comparison
CHB has a 0.67% expense ratio, which is higher than SPY's 0.09% expense ratio.
Risk-Adjusted Performance
CHB vs. SPY — Risk-Adjusted Performance Rank
CHB
SPY
CHB vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X China Biotech Innovation ETF (CHB) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CHB vs. SPY - Dividend Comparison
CHB has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.16%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHB Global X China Biotech Innovation ETF | 0.00% | 101.26% | 0.48% | 0.21% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.16% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
CHB vs. SPY - Drawdown Comparison
Volatility
CHB vs. SPY - Volatility Comparison
The current volatility for Global X China Biotech Innovation ETF (CHB) is 0.00%, while SPDR S&P 500 ETF (SPY) has a volatility of 3.13%. This indicates that CHB experiences smaller price fluctuations and is considered to be less risky than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.